71 related articles for article (PubMed ID: 3209276)
1. Prediction of steady-state plasma theophylline concentration by Bayesian algorithm.
Imaeda N; Takagi K; Hasegawa T; Saito H; Mizukami Y
Int J Clin Pharmacol Ther Toxicol; 1988 Dec; 26(12):588-93. PubMed ID: 3209276
[TBL] [Abstract][Full Text] [Related]
2. Absorption of theophylline from a sustained-release theophylline tablet formulation, Theo-Dur.
Takagi K; Hasegawa T; Ogura Y; Yamaki K; Suzuki R; Satake T; Imaeda N; Mizukami Y
Int J Clin Pharmacol Ther Toxicol; 1987 Oct; 25(10):530-5. PubMed ID: 3429057
[TBL] [Abstract][Full Text] [Related]
3. Prediction of steady-state serum theophylline concentration in children by first-order and zero-order absorption models.
Kato Z; Fukutomi O; Yamazaki M; Kondo N; Imaeda N; Orii T
Int J Clin Pharmacol Ther; 1994 May; 32(5):231-4. PubMed ID: 7921516
[TBL] [Abstract][Full Text] [Related]
4. A comparison of absorption rate models in the prediction of steady-state plasma concentrations during oral theophylline administration.
Paterson CM; Hudson SA; Jefferson GC
J Clin Pharm Ther; 1987 Feb; 12(1):39-46. PubMed ID: 3449562
[TBL] [Abstract][Full Text] [Related]
5. Absorption of theophylline from conventional and sustained-release tablets.
Fagerström PO; Mellstrand T; Svedmyr N
Int J Clin Pharmacol Ther Toxicol; 1981 Mar; 19(3):131-8. PubMed ID: 7228455
[TBL] [Abstract][Full Text] [Related]
6. Absorption of theophylline from conventional and sustained-release tablets.
Mellstrand T; Svedmyr N; Fagerström PO
Eur J Respir Dis Suppl; 1980; 109():54-60. PubMed ID: 6934088
[TBL] [Abstract][Full Text] [Related]
7. Accuracy of 11 methods for predicting theophylline dose.
Rodvold KA; Paloucek FP; Zell M
Clin Pharm; 1986 May; 5(5):403-8. PubMed ID: 3720210
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic comparison of a once-daily and twice-daily theophylline delivery system.
González MA; Kisicki J; Straughn AB
Clin Ther; 1994; 16(4):686-92. PubMed ID: 7982257
[TBL] [Abstract][Full Text] [Related]
9. [The usefulness of the bayesian method for the prediction of plasma theophylline levels in asthmatic children during RTC therapy by the sustained preparation of theophylline].
Okabe T; Hida M; Maruyama K; Kohgo T; Shibuya M; Ohashi A
Arerugi; 1994 Apr; 43(4):563-70. PubMed ID: 8031252
[TBL] [Abstract][Full Text] [Related]
10. Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis.
Zhou H; Mayer PR; Wajdula J; Fatenejad S
J Clin Pharmacol; 2004 Nov; 44(11):1235-43. PubMed ID: 15496641
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic variability of nimodipine disposition after single and multiple oral dosing to hypertensive renal failure patients: parametric and nonparametric population analysis.
Terziivanov D; Atanasova I; Dimitrova V; Robeva R; Unger S; Mück W
Int J Clin Pharmacol Ther; 1999 Aug; 37(8):404-12. PubMed ID: 10475143
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of theophylline in beagle dogs and asthmatic patients after multiple oral doses of sustained-release theophylline tablet formulation.
Nosaka H; Takagi K; Hasegawa T; Ogura Y; Mizukami Y; Satake T
Int J Clin Pharmacol Ther Toxicol; 1986 Oct; 24(10):528-35. PubMed ID: 3781672
[TBL] [Abstract][Full Text] [Related]
13. Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)--plasma levels after single and multiple oral doses.
Schuppan D; Molz KH; Staib AH; Rietbrock N
Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):223-7. PubMed ID: 7251238
[TBL] [Abstract][Full Text] [Related]
14. Comparison of aminophylline and theophylline sustained-release formulations by their bioavailability and steady-state serum levels.
Steinijans VW; Zech K; Fischer R
Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):624-30. PubMed ID: 6668100
[TBL] [Abstract][Full Text] [Related]
15. Individualization of theophylline dosage: a Bayesian method evaluated in patients with once-daily dosing.
Martz W; Oellerich M; Schnabel D; Sybrecht GW
Ther Drug Monit; 1991 Sep; 13(5):420-4. PubMed ID: 1957334
[TBL] [Abstract][Full Text] [Related]
16. Comparative steady-state bioavailability of Theo-24 and Theo-Dur in healthy men.
Dockhorn RJ; Cefali EA; Straughn AB
Ann Allergy; 1994 Mar; 72(3):218-22. PubMed ID: 8129214
[TBL] [Abstract][Full Text] [Related]
17. [Can we use a Bayesian method to build a pharmacokinetic population in two steps?].
Cabelguenne D; Bleyzac N; Pivot C; Maire P
Therapie; 2000; 55(2):277-82. PubMed ID: 10967700
[TBL] [Abstract][Full Text] [Related]
18. Population pharmacokinetics and bayesian estimator of cyclosporine in pediatric renal transplant patients.
Irtan S; Saint-Marcoux F; Rousseau A; Zhang D; Leroy V; Marquet P; Jacqz-Aigrain E
Ther Drug Monit; 2007 Feb; 29(1):96-102. PubMed ID: 17304156
[TBL] [Abstract][Full Text] [Related]
19. Variations in absorption of theophylline from two sustained-release products.
Ferrari M; Olivieri M; Barozzi E; Ramponi C
Clin Ther; 1986; 8(6):646-54. PubMed ID: 3791362
[TBL] [Abstract][Full Text] [Related]
20. Nonparametric population modeling of valproate pharmacokinetics in epileptic patients using routine serum monitoring data: implications for dosage.
Bondareva IB; Jelliffe RW; Sokolov AV; Tischenkova IF
J Clin Pharm Ther; 2004 Apr; 29(2):105-20. PubMed ID: 15068399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
